ResMed Inc.
RMD

$34.83 B
Marketcap
$237.27
Share price
Country
$5.69
Change (1 day)
$260.49
Year High
$164.12
Year Low

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

marketcap

P/E ratio for ResMed Inc. (RMD)

P/E ratio as of 2024: 26.92

According to ResMed Inc.'s latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 26.92. At the end of 2023 the company had a P/E ratio of 35.73.

P/E ratio history for ResMed Inc. from 1993 to 2024

PE ratio at the end of each year

Year P/E ratio
2024 26.92
2023 35.73
2022 39.28
2021 75.49
2020 44.58
2019 43.78
2018 46.86
2017 32.16
2016 25.16
2015 22.44
2014 20.75
2013 20.80
2012 17.86
2011 20.79
2010 24.14
2009 21.03
2008 25.07
2007 47.74
2006 38.49
2005 34.97
2004 29.97
2003 28.33
2002 23.88
2001 135.33
2000 36.30
1999 30.33
1998 31.23
1997 23.73
1996 25.50
1995 18.75
1994 29.86
1993 40.31